logo
Share SHARE
FONT-SIZE Plus   Neg

CACI International Q2 Profit Rises; Lifts FY12 EPS Estimate - Quick Facts

CACI International Inc. (CACI) reported second-quarter net income attributable to the company of $41.1 million or $1.51 per share, compared to $33.2 million or $1.08 per share in the prior year quarter.

Pro forma adjusted net income attributable to the company for the quarter rose to $54.4 million or $2.00 per share from $45.9 million or $1.48 per share in the comparable quarter last year.

On average, 16 analysts polled by Thomson Reuters expected earnings of $1.30 per share for the quarter. Analysts' estimates typically exclude one-time items.

Revenues for the quarter grew 12.2 percent to $973.24 million from $867.28 million last year, while fifteen analysts estimated revenues of $952.78 million for the quarter.

Looking forward to the fiscal year 2012, the company raised its earnings guidance range to $5.72 - $5.94 per share, from the prior estimate of $5.55 - $5.80 per share. Analysts currently estimate earnings of $5.67 per share for the full year.

The company expects its revenue guidance for the full year 2012 to the range of $3,850 million to $4,050 million, same as the prior estimate. Analysts currently estimate revenues of $3.92 billion for the full year.

by RTT Staff Writer

For comments and feedback: editorial@rttnews.com

Business News

Editors Pick
The holiday throng seeking to take a flight out to their preferred destinations at the at New York's Kennedy International Airport ahead of the Memorial Day holiday were in for a rude shock. Technology played a spoilsport, as a computer system broke down Sunday evening at a terminal, causing flight delays and cancellations that resulted in manual check-in process for thousands of holiday passeng The month of May saw the FDA greenlight 5 new drugs, including 1 new molecular entity, and surprisingly turn down 1 drug candidate, whose approval was considered a no-brainer by some experts. Lab equipment maker Thermo Fisher Scientific Inc. has agreed to acquire electron microscope maker FEI Co. for about $4.2 billion in cash, the two companies said Friday. Thermo Fisher noted that FEI's electron microscopy platform will complement its own mass spectrometry systems to accelerate advancements in structural biology.
comments powered by Disqus
Follow RTT